Cambridge-based global health research company TriNetX has secured $40 million in Series D funding, according to company database Crunchbase, topping the city’s recent funding headlines. The cash infusion was announced March 13.
According to its Crunchbase profile, "TriNetX is the global health research network enabling healthcare organizations, biopharmaceutical companies and contract research organizations to collaborate, enhance trial design, improve site selection and planning, and bring new therapies to market faster. TriNetX combines real-time access to longitudinal clinical data with state-of-the-art analytics to answer complex research questions at the speed of thought."
The six-year-old company also raised a $2.5 million convertible note round in 2016.
The round brings total funding raised by Cambridge companies in data and analytics over the past month to $143 million. The local data and analytics industry has produced 41 funding rounds over the past year, yielding a total of $1.6 billion in venture funding.
In other local funding news, scientific data management company Ovation announced a $5 million funding round on March 14, led by Madrona Venture Group.
According to Crunchbase, "Ovation provides data and operations solutions to researchers, scientists and labs throughout the life sciences industry."
Our offering for researchers includes cloud based storage for data related to experiments and analyses that enables easy collaborations within and between labs, and technology that allows researchers to describe and visualize the relationships between their data. Our offering for service labs in the precision medicine space is a first-of-its-kind solution that merges training records, document management, and sample tracking in an easy, cloud-based application."
The company also raised a $1.8 million seed round in 2018.
This story was created automatically using local investment data, then reviewed by an editor. Click here for more about what we're doing. Got thoughts? Go here to share your feedback.
